Bioregulator peptides

Livagen

A short bioregulator peptide studied mostly in Russian laboratory research on aging cells.

Laboratory research
Type
Short peptide (bioregulator)
Research area
Bioregulator peptides
Research stage
Laboratory research; limited clinical use outside the U.S.
FDA status
Not an FDA-approved medicine

About Livagen

A short bioregulator peptide studied mostly in Russian laboratory research on aging cells.

Where the research stands

Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.

Read the studies

Educational information only; not medical advice. Talk to a licensed doctor before using any compound.

Common questions

Is Livagen an FDA-approved medicine?

No. Livagen is not an FDA-approved medicine. Research stage: Laboratory research; limited clinical use outside the U.S..

Does EKO Labs sell Livagen?

No. EKO Labs does not sell Livagen or any research compound. This library is for education only. EKO Labs offers FDA-approved prescription treatments only after a licensed doctor decides they are right for you.

Can people use Livagen?

This page does not cover personal use. Products labeled "research use only" are not made or approved for people. Ask a licensed doctor before using any compound.

What is the molecular formula of Livagen?

According to PubChem (U.S. National Library of Medicine), Livagen has the molecular formula C18H31N5O9 and a molar mass of about 461.5 g/mol.

Real molecular structure

The molecule: Livagen

Drag to rotate. Every atom and bond below comes from the public PubChem database of the U.S. National Institutes of Health; nothing is drawn by AI.

2D structure, tilted in 3DCNOS
Livagen 2D chemical structure
Formula
C18H31N5O9
Molar mass
461.5 g/mol
Heavy atoms
32
PubChem CID
87919683 ↗

Source: PubChem, National Library of Medicine (public domain).